期刊
TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT
卷 34, 期 11, 页码 1249-1262出版社
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/09537325.2021.1950678
关键词
Antimicrobial resistance; livestock; rapid diagnostics; point-of-care diagnostics
资金
- Antimicrobial Resistance Cross Council Initiative - Seven UK Research Councils in Partnership [ES/P008194/1]
Antimicrobial resistance is a major public health threat, and reducing antimicrobial use in livestock is crucial to prevent its spread. Future support for RDT development could involve incorporating them into assured food systems, offering business service packages, or animal health monitoring packages to address the issue.
Antimicrobial resistance (AMR) is one of today's greatest public health threats and reducing antimicrobial use in livestock is essential to prevent its spread, requiring rapid diagnostic tests (RDTs) to ensure that the drug prescribed matches the sensitivity of the disease organism. However, despite decades of research on RDTs and a relatively permissive regulatory environment in the UK, few devices are in commercial use. Challenges discussed by RDT developers included identifying commercially-viable targets, and management of the innovation ecosystem, e.g. to create clear pathways to market supporting positive interactions between farmers, vets, and other actors along the value chain. Future support for RDT development could be provided through incorporation in: assured food systems; business service packages provided by centralised laboratories; or animal health monitoring packages related to the spread of AMR. Breeding stock sales could require an accompanying health package including RDTs, vaccines and/or antibiotics, linking to precision agriculture approaches. Unlike the example of RDT development for COVID-19, it seems that the urgency of the issue and the clarity of links between animal and human health outcomes are not yet sufficient to support a fast-tracking programme for the development of RDTs to combat AMR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据